Syros Pharmaceuticals, Inc. 13D and 13G filings for Flexible Solutions International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-13 5:10 pm Purchase |
2022-07-03 | 13D | Flexible Solutions International, Inc. FSI |
Syros Pharmaceuticals Inc. SYRS |
17,819,723 9.900% |
17,819,723 (New Position) |
Filing |